text:
On the same day Cardinals ownership backed coach Ken Whisenhunt (for the rest of the season, anyway), the Cardinals went to the waiver wire for an option.
According to ESPN's Adam Schefter, the Cards claimed Brian Hoyer off waivers from the Steelers. Hoyer was released Saturday when Ben Roethlisberger healed and he was deemed surplus to requirements.
On any other team, at any other time, Hoyer would be a line of agate type.
There's a cynical-if-not-reasonable argument to be made he's the Cardinals best quarterback at the moment, with Kevin Kolb hurt and John Skelton and Ryan Lindley in a turnover race.

subset: commoncrawl


text:
The Ph.D. programme in Foreign Literatures, Languages and Linguistics aims to promote high-level academic education based on the integration of linguistic, literary and cultural studies, also including Digital-Humanities related aspects, in order to build critical awareness of the multicultural and multilingual reality of Europe and of the world, as well as the ability to act upon such reality. Ph.D. students will acquire the methodological and theoretical tools they need for their own research, which will be conducted in various cultural and professional fields relating to the research areas. The Ph.D. programme is subdivided into three tracks/"curricula".
In the first curriculum, Foreign Literatures and Cultures, the contributions of literary theory will enhance an interdisciplinary and intercultural approach, providing the necessary tools for a constant update of aesthetic and historical interrelations and fostering a close investigation into the relationship between literary text and context, and between literary works and relative knowledge.
In the second curriculum, Foreign Languages and Translation Studies, the different languages in the programme (English, German, Spanish, French, Russian and Chinese) will be analysed with specific reference to their diachronic, diastratic, diatopic and diaphasic variations. Particular attention will be devoted to terminology, lexicology and lexicography, as well as to comparative translation studies, combining different methodologies for the analysis of texts, including the use of linguistic corpora.
Finally, the international curriculum in Linguistics will provide high-level education in the different areas of linguistics, as well as specific formation in fields such as the study of Germanic-Romance language contact, language pathologies, first and second language acquisition/learning, historical linguistics and Indo-European comparative linguistics. It will offer training in traditional methodologies (such as dialectology studies), laboratory research (such as acoustic analyses of audio data) and experimental studies (both with behavioral techniques, e.g., priming and eye-tracking, and neurophysiological techniques, e.g., EEG).


text:
President Obama has apparently decided to change another of Ronald Reagan's policies. President Reagan famously said "Trust but Verify" when dealing with the Russians. With President Obama, our new policy will be to "Trust the Russians to Verify" whether Syria's Assad has complied with UN directives on chemical weapons.
The President's confused and confusing speech this week raised more questions than it answered. One of the most important questions isn't even being asked by our foreign policy elites: Why should the U.S. back the Syrian rebels who are slaughtering Christians in that war-racked country? Why should any American Christian support going to war for these rebels in Syria?
Until the Russians threw Mr. Obama a lifeline, we were preparing to align ourselves with persecutors of Christians in that country's civil war. Bashar al-Assad has committed heinous crimes, to be sure, including the use of chemical weapons. But he has not aggressively persecuted Christians--as the rebels have done and are doing. Hundreds of thousands of Christians in Syria are in danger. Many of them have lived in that country since biblical times.
Tens of thousands of Christians in Syria are refugees from Iraq. The U.S. invasion of Iraq has been a catastrophe for the two million Christians who once lived precariously there. How bad must post-Saddam Iraq be when only 400,000 Christians are left there? And we must always remember that U.S. arms helped bring about the destruction of this ancient Christian community.
The victory of the rebel jihadists in Syria can only bring more death and persecution to these historic church communities.
Unlike Secretary John Kerry, we should never have held out hope that Bashar al-Assad would be "a reformer." Conservatives remember what his father had done to secure power in 1982. Hafez al-Assad massacred more than 20,000 people in a ruthless display of bloodletting in the city of Hama.
Hafez al-Assad was only the latest in the long line of Mideast despots. We see his like in the story of King Herod, who was willing to slaughter infants by the hundreds in order to hold onto his shaky throne. What is different today is chemical weapons and cell phones. Not the evil that these brutal rulers do.
Secretary Chuck Hagel says if we go to war, it will be to "degrade their [Assad's forces'] capability" Has there ever been a foggier goal for military action? What does that mean? Are we sure that in the course of degrading their capability we will not be degrading our own? Sen. Jim Inhofe (R-OK) warns that with Obama's drastic cuts to our military, we cannot adequately deal with the predictable consequences of a military strike on Assad.
Can President Obama justify the loss of a single American life in order to "degrade their capability"? Sen. McCain "guarantees" they are moderates. What does moderate mean in the Mideast? We have the Muslim Brotherhood chieftain in Egypt saying--so moderately--there should be no chopping off of hands in the first five years of his party's rule.
Democracy can never take root in a country where most of the people believe their neighbors who worship differently should be killed. Purple fingers may cast ballots, but if they also burn churches, there will be no shoots of democracy coming up from the sand in any Arab Spring.
Mr. Kerry has compared the need for action in Syria to the refusal of the Roosevelt administration to give refuge to the stranded Jews aboard the vessel Saint Louis. That is almost an obscene comparison. No Jews could survive in the regime that would be set up by the jihadists he wants us to aid. And soon, no Christians will be tolerated, either.
When Saul of Tarsus rode to Damascus in order to kill the Christians there, Jesus appeared to him in a blinding light. "Why are you persecuting me?" Jesus asked him. The Lord saw the murders that Saul planned as direct attacks on Jesus Himself.
Now, we Christians in America are asked to support forces in Syria whose murderous plans for the Christians in Damascus are clear. And instead of seeing Roman soldiers casting lots for Jesus' robe around the foot of the Cross, we can see our own senators playing video poker as they plot their next move.


text:
Participating Organization(s) |
National Institutes of Health (NIH) |
National Cancer Institute (NCI) |
Funding Opportunity Title |
NIH Revision Applications for Research Relevant to the Family Smoking Prevention and Tobacco Control Act (P30) |
Activity Code |
P30 Center Core Grants |
Announcement Type |
New |
Related Notices |
Funding Opportunity Announcement (FOA) Number |
Companion Funding Opportunity |
None |
Catalog of Federal Domestic Assistance (CFDA) Number(s) |
93.077 |
Funding Opportunity Purpose |
This Funding Opportunity Announcement (FOA) invites revision applications from investigators and institutions/organizations with active National Institutes of Health (NIH)-supported P30 project awards to support an expansion of the scope of approved and funded scientific research programs involving smoking and tobacco-related products and/or their constituents. Investigators and institutions/organizations that are on a funded extension are eligible to apply for a revision. Revision applications for projects that have not originally focused on tobacco use are welcome provided that the applicant team has the requisite scientific expertise and the proposed revision addresses the research priorities related to Food and Drug Administration (FDA) regulatory authority that are identified in the FOA. The NIH and the FDA have formed an interagency partnership to foster research relevant to tobacco regulations. The awards under this FOA will be administered by NIH using designated funds from the FDA Center for Tobacco Products (CTP) for tobacco regulatory science mandated by the Family Smoking Prevention and Tobacco Control Act (FSPTCA), Public Law 111-31. Projects resulting from this FOA are expected to serve the FDA by generating relevant findings and data needed to inform the regulation of the manufacture, distribution, and marketing of tobacco products to protect public health. |
Posted Date |
December 18, 2012 |
Letter of Intent Due Date(s) |
February 26, 2013 |
Application Due Date(s) |
March 26, 2013 |
AIDS Application Due Date(s) |
Not Applicable |
Scientific Merit Review |
June 2013 |
Advisory Council Review |
August 2013 |
Earliest Start Date |
December 1, 2013 |
Expiration Date |
March 27, 2013 |
Due Dates for E.O. 12372 |
Not Applicable |
Required Application Instructions
It is critical that applicants follow the instructions in the PHS 398 Application Guide except where instructed to do otherwise (in this FOA or in a Notice from the NIH Guide for Grants and Contracts). Conformance to all requirements (both in the Application Guide and the FOA) is required and strictly enforced. While some links are provided, applicants must read and follow all application instructions in the Application Guide as well as any program-specific instructions noted in Section IV. When the program-specific instructions deviate from those in the Application Guide, follow the program-specific instructions. Applications that do not comply with these instructions may be delayed or not accepted for review.
Looking ahead: NIH is committed to transitioning all grant programs to electronic submission using the SF424 Research and Related (R&R) format and is currently investigating solutions that will accommodate NIH's multi-project programs. NIH will announce plans to transition the remaining programs in the NIH Guide to Grants and Contracts and on NIH's Applying Electronically website.
Part 1. Overview Information
Part 2. Full Text of Announcement
Section I. Funding Opportunity Description
Section II. Award Information
Section III. Eligibility Information
Section IV. Application and Submission
Section V. Application Review Information
Section VI. Award Administration Information
Section VII. Agency Contacts
Section VIII. Other Information
This Funding Opportunity Announcement (FOA) invites revision applications to active National Institutes of Health (NIH)-funded P30 research center awards to expand the scope of approved and funded formal scientific research programs involving smoking or tobacco related products and/or their constituents. Revision applications for center projects that have not originally focused on tobacco use are also welcome provided that the applicant team has the requisite scientific expertise and the proposed revision addresses the research priorities related to FDA regulatory authority that are identified in the FOA. All applicants responding to this FOA are expected to propose one to four research projects/pilots that respond to the priorities of the FDA Center for Tobacco Products as outlined in the Specific Research Objectives and Scope below.
The awards under this FOA will be administered by NIH using designated funds [from the FDA CTP] for tobacco regulatory science mandated by the Family Smoking Prevention and Tobacco Control Act (FSPTCA), Public Law 111-31. The NIH and the FDA have formed an interagency partnership to foster research relevant to tobacco regulatory science within the framework of the Tobacco Control Act. Consistent with the FDA CTP mission, this FOA encourages research applications that address such aspects as: understanding the diversity of tobacco products, reducing addiction to tobacco products, reducing toxicity and carcinogenicity of tobacco products and smoke, understanding the adverse health consequences of tobacco use, understanding communications about tobacco products, understanding tobacco product marketing, and understanding how economics and policies affect tobacco product use (http://cancercontrol.cancer.gov/nih-fda/).
With the passage of the FSPTCA in June 2009, the FDA acquired the authority to regulate the manufacture, marketing, and distribution of tobacco products in order to protect public health. Under Section 901 of the FSPTCA, the FDA has authority to regulate tobacco products. A tobacco product is defined as any product made or derived from tobacco that is intended for human consumption, including any component, part or accessory of a tobacco product (except for raw materials other than tobacco used in manufacturing a component, part, or accessory or a tobacco product). As of August 2011, FDA's jurisdiction of tobacco products included all cigarettes, cigarette tobacco, roll-your-own tobacco, and smokeless tobacco. It is anticipated that FDA will assert jurisdiction over all other tobacco products currently not under its jurisdiction that meet the statutory definition of tobacco product. (Regulation Identification Number 0910-AG38, Regulation of E-Cigarettes and Other Tobacco Products). A full description of the FSPTCA can be found at: http://www.fda.gov/downloads/TobaccoProducts/GuidanceComplianceRegulatoryInformation/UCM237080.pdf. Potential applicants should be aware of the requirements of revised Circular A-110, see: http://grants.nih.gov/archive/grants/policy/a110/a110_guidance_dec1999.htm#faqs.
Science will inform the FDA in regulation of the manufacture, marketing, and distribution of tobacco products in order to reduce the public health toll from tobacco product use in the United States. By way of background, FDA CTP developed a list of 56 research priorities that can be found at: http://cancercontrol.cancer.gov/nih-fda/research.htm.
This FOA is focused on the following ten FDA CTP interest areas. Only applications proposing research projects/pilots relevant to one or more of these ten areas will be considered for funding.
1. Nicotine dependence threshold among youth and adults and impact of nicotine reduction on tobacco product use behavior (e.g., topography, compensation, switching, multiple use, initiation, cessation, relapse)
2. Cigar (small, large, cigarillos) initiation, use (including transitions to other tobacco products and multiple use), perceptions, dependence and toxicity
3. Smokeless tobacco initiation, use (including transitions to other tobacco products and multiple use), perceptions, dependence and toxicity
4. E-cigarettes initiation, use (including transitions to other tobacco products and multiple use), perceptions, dependence, toxicity
5. Other tobacco product (e.g., hookah, pipes, dissolvables) initiation, use (including transitions to other tobacco products and multiple use), perceptions, dependence, toxicity
6. The impact of tobacco product characteristics, (e.g., ingredients, constituents, components, additives such as flavors, and labeling and marketing) on initiation, especially among youth and other vulnerable populations
7. Toxicity thresholds for each of the 20 harmful and potentially harmful constituents identified in the March 2012 Guidance for Industry http://www.fda.gov/TobaccoProducts/GuidanceComplianceRegulatoryInformation/ucm297752.htm
8. Statistical modeling of the public health impact of FDA/CTP regulation of potential modified risk tobacco products, e.g., product standards, communications regarding risks of tobacco products
9. Consumer perceptions of tobacco products including the impact of labeling and marketing
10. Effective communication strategies regarding harmful and potentially harmful constituents and risks of tobacco products
Activities that are NOT appropriate for revision applications under this FOA (even if they are oriented to tobacco regulatory science) include, but are not limited to the following:
Funding Instrument |
Grant: A support mechanism providing money, property, or both to an eligible entity to carry out an approved project or activity. |
Application Types Allowed |
Revision applications from investigators with active P30 awards issued by one of the participating Institute/Centers (ICs) listed in this FOA The OER Glossary and the PHS 398 Application Guide provide details on these application types. |
Funds Available and Anticipated Number of Awards |
The number of awards is contingent upon the submission of a sufficient number of meritorious applications. NIH, via support from the FDA Center for Tobacco Products (CTP), intends to fund approximately 20 awards, corresponding to a total cost of $20 million, for fiscal year 2014. Only one revision application per P30 award is allowed. The application may include up to four individual research projects/pilots. |
Award Budget |
Revision applications may not exceed $1,000,000 in total costs per year, and application budgets need to reflect actual scope and needs of the proposed project(s). |
Award Project Period |
Applicants may request support for up to 2 years, not to exceed the remaining number of years on the parent grant and/or the funded extension per the Notice of Award, and/or the no-cost extension. If a no-cost extension is needed on the parent grant to incorporate the project period of the revision, the no-cost extension must be in place before the revision application is submitted. |
NIH grants policies as described in the NIH Grants Policy Statement will apply to the applications submitted and awards made in response to this FOA.
Higher Education Institutions
The following types of Higher Education Institutions are always encouraged to apply for NIH support as Public or Private Institutions of Higher Education:
Non-domestic (non-U.S.) Entities (Foreign Institutions) are
not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible
to apply.
Foreign components, as defined in
the NIH Grants Policy Statement, are allowed.
Applicant organizations must complete the following registrations as described in the PHS 398 Application Guide to be eligible to apply for or receive an award. Applicants must have a valid Dun and Bradstreet Universal Numbering System (DUNS) number in order to begin each of the following registrations.
All Program Directors/Principal Investigators (PD(s)/PI(s)) must also work with their institutional officials to register with the eRA Commons or ensure their existing eRA Commons account is affiliated with the eRA Commons account of the applicant organization.
All registrations must be completed by the application due date. Applicant organizations are strongly encouraged to start the registration process at least 6 weeks prior to the application due date.
Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support.
This FOA does not require cost sharing as defined in the NIH Grants Policy Statement.
Only one application per P30 award (normally identified as having a unique DUNS number or IPF number) is allowed.
NIH will not accept any application that is essentially the same as one already reviewed within the past thirty-seven months (as described in the NIH Grants Policy Statement), except for submission:
Applicants are required to prepare applications according to the current PHS 398 application forms in accordance with the PHS 398 Application Guide.
It is critical that applicants follow the instructions in the PHS 398 Application Guide, except where instructed in this funding opportunity announcement to do otherwise. Conformance to the requirements in the Application Guide is required and strictly enforced. Applications that are out of compliance with these instructions may be delayed or not accepted for review.
Although a letter of intent is not required, is not binding, and does not enter into the review of a subsequent application, the information that it contains allows IC staff to estimate the potential review workload and plan the review.
By the date listed in Part 1. Overview Information, prospective applicants are asked to submit a letter of intent that includes the following information:
The letter of intent should be sent to:
Glen Morgan, PhD
National Cancer Institute
6130 Executive Boulevard, room 4038
Rockville, MD 20852
Telephone: 301-496-8585
Email: firstname.lastname@example.com
Applications must be prepared using the PHS 398 research grant application forms and instructions for preparing a research grant application. Submit a signed, typewritten original of the application, including the checklist, and five signed photocopies in one package to:
Center for Scientific Review
National Institutes of Health
6701 Rockledge Drive, Room 1040, MSC 7710
Bethesda, MD 20892-7710 (U.S. Postal Service Express or regular mail)
Bethesda, MD 20817 (for express/courier service; non-USPS service)
All page limitations described in the PHS 398 Application Guide and the Table of Page Limits must be followed, with the following exceptions or additional requirements:
All applicants responding to this FOA must propose one to four research projects that respond to one or more areas of research interested defined above. If the applicant proposes one research project, then the PHS398 Application Guide and forms should be followed in entirety. If the applicant proposes two to four research projects, then one application should be prepared using the PHS398 Application Guide and forms, but the Research Plan section should be repeated for each of the projects.
Detailed budgets must be submitted. Modular budgets will not be accepted regardless of total costs.
All instructions in the PHS 398 Application Guide must be followed, with the following additional instructions:
Research Strategy
Resource Sharing Plan
Individuals are required to comply with the instructions for the Resource Sharing Plans (Data Sharing Plan, Sharing Model Organisms, and Genome Wide Association Studies (GWAS)) as provided in the PHS 398 Application Guide, with the following modification:
Do not use the Appendix to circumvent page limits. Follow all instructions for the Appendix (please note all format requirements) as described in the PHS 398 Application Guide.
Part I. Overview Information contains information about Key Dates.
Information on the process of receipt and determining if
your application is considered on-time is described in detail in the PHS 398
Application Guide.
Applicants may track the status of the application in the eRA Commons, NIH's electronic system for grants
This initiative is not subject to intergovernmental review.
All NIH awards are subject to the terms and conditions, cost
principles, and other considerations described in the NIH
Grants Policy Statement.
Pre-award costs are allowable only as described in the NIH
Grants Policy Statement.
Awards funded under this FOA are not subject to SNAP authorities and do not have authority for the carryover of unobligated balances from budget perioed to any subsequent budget period without prior written approval from NIH. Special reporting requirements also apply, as described in Section VI.3 Reporting.
Applications must be received on or before the due dates in Part I. Overview Information. If an application is received after that date, it will not be reviewed.
Upon receipt, applications will be evaluated for completeness by the Center for Scientific Review and responsiveness by FDA and components of participating organizations, NIH. Applications that are incomplete and/or nonresponsive will not be reviewed.
Applicants are required to follow the instructions for post-submission materials, as described in NOT-OD-10-115.
Only the review criteria described below will be considered
in the review process. As part of the NIH mission,
all applications submitted to the NIH in support of biomedical and behavioral
research are evaluated for scientific and technical merit through the NIH peer
review system.
Reviewers will provide an overall impact score to reflect their assessment of the likelihood for the project to exert a sustained, powerful influence on the research field(s) involved, in consideration of the following review criteria and additional review criteria (as applicable for the project proposed).
Reviewers will consider each of the review criteria below in the determination of scientific merit, and give a separate score for each. An application does not need to be strong in all categories to be judged likely to have major scientific impact. For example, a project that by its nature is not innovative may be essential to advance a field.
Does the project address an important issue or a critical barrier in regulatory authority over tobacco products? If the aims of the project are achieved, how will regulatory science research be informed or regulation be affected? How will successful completion of the aims affect the concepts, methods, technologies, or regulation of tobacco products?
Are the PD(s)/PI(s), collaborators, and other researchers well suited to the project? If Early Stage Investigators or New Investigators, or in the early stages of independent careers, do they have appropriate experience and training? If established, have they demonstrated an ongoing record of accomplishments that have advanced their field(s)? If the project is collaborative or multi-PD/PI, do the investigators have complementary and integrated expertise; are their leadership approach, governance and organizational structure appropriate for the project?
Will the project aid in advancement of developing and evaluating regulations pertaining to the manufacture, distribution, and marketing of tobacco products in order to protect public health? Will the outcomes of the project provide new information addressing regulatory authority over tobacco products?
Are the overall strategy, methodology, and analyses well-reasoned and appropriate to accomplish the specific aims of the project? Are potential problems, alternative strategies, and benchmarks for success presented? Is the project directly relevant to a specific section the Family Smoking Prevention and Tobacco Control Act? If the project is in the early stages of development, will the strategy establish feasibility and are any risky aspects addressed?
If the project involves clinical research, are the plans for 1) protection of human subjects from research risks, and 2) inclusion of minorities and members of both sexes/genders, as well as the inclusion of children, justified in terms of the scientific goals and research strategy proposed?
Will the scientific environment in which the work will be done contribute to the probability of success? Are the institutional support, equipment and other physical resources available to the investigators adequate for the project proposed? Will the project benefit from unique features of the scientific environment, subject populations, or collaborative arrangements?
As applicable for the project proposed, reviewers will evaluate the following additional items while determining scientific and technical merit, and in providing an overall impact score, but will not give separate scores for these items.
Protections for Human Subjects
For research that involves human subjects but does
not involve one of the six categories of research that are exempt under 45 CFR
Part 46, the committee will evaluate the justification for involvement of human
subjects and the proposed protections from research risk relating to their
participation according to the following five review criteria: 1) risk to
subjects, 2) adequacy of protection against risks, 3) potential benefits to the
subjects and others, 4) importance of the knowledge to be gained, and 5) data
and safety monitoring for clinical trials.
For research that involves human subjects and meets the criteria for one or
more of the six categories of research that are exempt under 45 CFR Part 46,
the committee will evaluate: 1) the justification for the exemption, 2) human
subjects involvement and characteristics, and 3) sources of materials. For
additional information on review of the Human Subjects section, please refer to
the Human
Subjects Protection and Inclusion Guidelines.
Inclusion of Women, Minorities, and Children
When the proposed project involves clinical research, the committee will evaluate the proposed plans for inclusion of minorities and members of both genders, as well as the inclusion of children. For additional information on review of the Inclusion section, please refer to the Human Subjects Protection and Inclusion Guidelines.
Vertebrate Animals
The committee will evaluate the involvement of live vertebrate animals as part of the scientific assessment according to the following five points: 1) proposed use of the animals, and species, strains, ages, sex, and numbers to be used; 2) justifications for the use of animals and for the appropriateness of the species and numbers proposed; 3) adequacy of veterinary care; 4) procedures for limiting discomfort, distress, pain and injury to that which is unavoidable in the conduct of scientifically sound research including the use of analgesic, anesthetic, and tranquilizing drugs and/or comfortable restraining devices; and 5) methods of euthanasia and reason for selection if not consistent with the AVMA Guidelines on Euthanasia. For additional information on review of the Vertebrate Animals section, please refer to the Worksheet for Review of the Vertebrate Animal Section.
Reviewers will assess whether materials or procedures proposed are potentially hazardous to research personnel and/or the environment, and if needed, determine whether adequate protection is proposed.
Not Applicable
Not Applicable
For Revisions, the committee will consider the appropriateness of the proposed expansion of the scope of the project. Revisions must address the research priorities related to the Food and Drug Administration (FDA) regulatory authority that are identified in the FOA.
As applicable for the project proposed, reviewers will consider each of the following items, but will not give scores for these items, and should not consider them in providing an overall impact score.
Applications from Foreign Organizations
Not Applicable
Select Agent Research
Reviewers will assess the information provided in this section of the application, including 1) the Select Agent(s) to be used in the proposed research, 2) the registration status of all entities where Select Agent(s) will be used, 3) the procedures that will be used to monitor possession use and transfer of Select Agent(s), and 4) plans for appropriate biosafety, biocontainment, and security of the Select Agent(s).
Resource Sharing Plans
Reviewers will comment on whether the following Resource Sharing Plans, or the rationale for not sharing the following types of resources, are reasonable: 1) Data Sharing Plan; 2) Sharing Model Organisms; and 3) Genome Wide Association Studies (GWAS).
Budget and Period of Support
Reviewers will consider whether the budget and the requested period of support are fully justified and reasonable in relation to the proposed research.
Applications will be evaluated for scientific and technical merit by (an) appropriate Scientific Review Group(s)convened by the Center for Scientific Review, in accordance with NIH peer review policy and procedures, using the stated review criteria. Application assignments to scientific review groups will be shown in the eRA Commons.
As part of the scientific peer review, all applications:
Appeals of initial peer review will not be accepted for applications submitted response to this FOA.
Applications will be assigned on the basis of established PHS referral guidelines to the appropriate NIH Institute or Center and will compete for available funds with all other recommended applications submitted in response to this FOA. Following initial peer review, recommended applications will receive a second level of review by the appropriate national Advisory Council or Board. The following will be considered in making funding decisions:
After the peer review of the application is completed, the PD/PI will be able to access his or her Summary Statement (written critique) via the eRA Commons.
Information regarding the disposition of applications is available in the NIH Grants Policy Statement.
If the application is under consideration for funding, NIH
will request "just-in-time" information from the applicant as
described in the NIH
Grants Policy Statement.
A formal notification in the form of a Notice of Award (NoA) will be provided
to the applicant organization for successful applications. The NoA signed by
the grants management officer is the authorizing document and will be sent via
email to the grantee's business official.
Awardees must comply with any funding restrictions described in Section IV.5. Funding Restrictions. Selection
of an application for award is not an authorization to begin performance. Any
costs incurred before receipt of the NoA are at the recipient's risk. These
costs may be reimbursed only to the extent considered allowable pre-award costs.
Any application awarded in response to this FOA will be subject to the DUNS, SAM
Registration, and Transparency Act requirements as noted on the Award
Conditions and Information for NIH Grants website.
All NIH grant and cooperative agreement awards include the NIH Grants Policy Statement as part of the NoA. For these terms of award, see the NIH Grants Policy Statement Part II: Terms and Conditions of NIH Grant Awards, Subpart A: General and Part II: Terms and Conditions of NIH Grant Awards, Subpart B: Terms and Conditions for Specific Types of Grants, Grantees, and Activities. More information is provided at Award Conditions and Information for NIH Grants.
Not Applicable
When multiple years are involved, awardees will be required to submit the Non-Competing Continuation Grant Progress Report (PHS 2590) annually and financial statements as required in the NIH Grants Policy Statement. An Interim Report will be due at the end of six (6) months following the project start date. Electronic copies should be sent to the Grants Management Specialist listed on the Notice of Grant Award. The scientific summary should be a maximum of (2) pages.
A final progress report, invention statement, and the expenditure data portion of the Federal Financial Report are required for closeout of an award, as described in the NIH Grants Policy Statement.
The Federal Funding Accountability and Transparency Act of 2006 (Transparency Act), includes a requirement for awardees of Federal grants to report information about first-tier subawards and executive compensation under Federal assistance awards issued in FY2011 or later. All awardees of applicable NIH grants and cooperative agreements are required to report to the Federal Subaward Reporting System (FSRS) available at www.fsrs.gov on all subawards over $25,000. See the NIH Grants Policy Statement for additional information on this reporting requirement.
We encourage inquiries concerning this funding opportunity and welcome the opportunity to answer questions from potential applicants.
GrantsInfo (Questions regarding application instructions and
process, finding NIH grant resources)
Telephone 301-710-0267
Email: firstname.lastname@example.com
eRA Commons Help Desk (Questions regarding eRA Commons
registration, tracking application status, post submission issues)
Phone: 301-402-7469 or 866-504-9552 (Toll Free)
Email: email@example.com
National Cancer Institute (NCI)
Glen Morgan, PhD
6130 Executive Boulevard, room 4038
Rockville, MD 20852
Telephone: 301-496-8585
Email: firstname.lastname@example.com
National Heart, Lung, and Blood Institute (NHLBI)
Antonello Punturieri, PhD
Division of Lung Diseases, MSC 7952
6701 Rockledge Dr.
Bethesda, MD, 20892-7952
Telephone: 301-435-0230
Email: email@example.com
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Abraham P. Bautista, PhD
5635 Fishers Ln, Room 2003, MSC 9304
Rockville, MD 20892-9304
Telephone: 301-443-9737
Email: firstname.lastname@example.com
National Institute on Drug Abuse (NIDA)
Minda R. Lynch, PhD
6001 Executive Blvd., MSC 9555
Rockville, MD 20852
Telephone: 301-435-1322
Email: email@example.com
National Institute of Mental Health (NIMH)
Amy Goldstein, PhD
Child and Adolescent Treatment & Preventive Intervention
Research Branch
6001 Executive Boulevard, Room 7144, MSC 9631
Bethesda, MD 20892-9631
Telephone: 301-496-7227
Email: firstname.lastname@example.com
Examine your eRA Commons account for review assignment and contact information (information appears two weeks after the submission due date).
National Cancer Institute (NCI)
Carol Perry
Telephone: 301-496-7205
Email: email@example.com
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Judy S. Fox
Telephone: 301-443-4704
Email: firstname.lastname@example.com
National Institute on Drug Abuse (NIDA)
Deborah Wertz
Telephone: 301-649-1715
Email: email@example.com
National Institute of Mental Health (NIMH)
Rebecca Claycamp, MS, CRA
Telephone: 301-443-2811
Email: email@example.com
Recently issued trans-NIH policy notices may affect your application submission. A full list of policy notices published by NIH is provided in the NIH Guide for Grants and Contracts. All awards are subject to the terms and conditions, cost principles, and other considerations described in the NIH Grants Policy Statement.
Awards are made under the authorization of Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 45 CFR Parts 74 and 92.
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
| ||||||
Department of Health and Human Services (HHS) |
NIH... Turning Discovery Into Health® Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files. |


text:
Andrew Maxwell, Michigan State rally past Indiana
BLOOMINGTON, Ind. -- Andrew Maxwell passed for 290 yards and two touchdowns, and Michigan State rallied from a 17-point deficit to defeat Indiana 31-27 on Saturday.
Aaron Burbridge caught eight passes for 134 yards and Le'Veon Bell ran for 121 yards and two touchdowns on 37 carries for the Spartans (4-2, 1-1 Big Ten), who were coming off a 17-16 loss to No. 12 Ohio State.
Cameron Coffman passed for 282 yards and three touchdowns and Shane Wynn had 12 catches for 70 yards for the Hoosiers (2-3, 0-2), who led 27-17 at the end of the third quarter. Indiana could have given second-year coach Kevin Wilson his first conference win, but the Hoosiers went three-and-out on critical back-to-back possessions in the fourth quarter.
Michigan State, which gave up nearly 200 yards in the first quarter, held Indiana to 37 yards and two first downs in the second half.
Indiana started Coffman over Nate Sudfeld at quarterback, and the Hoosiers' no-huddle offense rolled right down the field against one of the nation's best defenses. Coffman fired a 19-yard touchdown pass to Stephen Houston 77 seconds into the game.
Two possessions later, Mitch Ewald's 32-yard field goal made it 10-0 Hoosiers.
After Michigan State was called for a roughing-the-punter penalty, Coffman took advantage with a 21-yard touchdown pass to Ted Bolser with 38 seconds left in the first quarter.
Michigan State finally got it going in the second quarter. Bell scored from 2 yards out to cut Indiana's lead to 17-7.
Maxwell followed with a 15-yard touchdown pass to running back Larry Caper to trim Indiana's lead to 17-14 with 6:26 left in the first half.
Indiana came right back when Coffman found Wynn for a 17-yard touchdown pass. Indiana recovered an onside kick, and a 19-yard field goal by Ewald gave Indiana a 27-14 lead at halftime. Coffman completed 23 of 30 passes for 256 yards in the first half.
Michigan State got the ball first in the second half, and a 46-yard field goal by Dan Conroy cut Indiana's lead to 27-17.
Michigan State went for it on fourth down at the Indiana 2 and Bell got a yard on a play that was reviewed. Two plays later, Bell scored from the 1, cutting Indiana's lead to 27-24 with 7:49 to play.
Coffman missed on three straight passes, and Michigan State got the ball back 20 seconds after the previous score. On the third play of the possession, Maxwell connected with Bennie Fowler for a 36-yard touchdown pass to give the Spartans a 31-27 lead.
Indiana went three-and-out again and punted. Michigan State's Nick Hill fumbled the fair catch but fell on it, and Indiana got a personal-foul penalty, giving the Spartans the ball at the 50. Michigan State ran out the clock, clinching the game on a fourth-and-1 conversion by Bell on the Indiana 9-yard line in the final minute.
Game Information
2023 Big Ten Conference Standings
Team | CONF | OVR |
Michigan | 9-0 | 15-0 |
Ohio State | 8-1 | 11-2 |
Penn State | 7-2 | 10-3 |
Maryland | 4-5 | 8-5 |
Rutgers | 3-6 | 7-6 |
Michigan State | 2-7 | 4-8 |
Indiana | 1-8 | 3-9 |


text:
Nearly 100 varieties of hardy and tropical water-lilies and other aquatic plants, including elegant sacred lotuses, offer a stunning summer display on Lily Pool Terrace. Spectacular year-round, visitors enjoy the serene reflecting pools, fountains, and border gardens, which are also popular with local birdlife such as ducks and the occasional heron.
The centerpiece of Lily Pool Terrace is the Jenkins Fountain, located directly in front of the Palm House. Two large rectangular pools are situated to its north and south, bordered by the Mixed Perennial Border and Annual Border. BBG's Terrace Café is located just off the terrace.
The pools are planted with nearly 100 varieties of hardy and tropical water-lilies and sacred lotuses, creating a stunning attraction in July, August, and September. The Perennial Border, on the east side of Lily Pool Terrace, is a semipermanent installation of woody and herbaceous plants that offer a continuous display of bloom from spring through fall and lovely structural interest through the winter. The Annual Border, lining the west side of the pools, comes alive in early spring with its famed bulb display, including thousands of tulips, alliums, and other spectacular spring bloomers. Each summer brings a unique new design of colorful flowers and foliage plants created by the garden's curator.
Sacred lotus (Nelumbo nucifera) cultivars
There are several species and cultivars of sacred lotus (Nelumbo nucifera) in BBG's lily pools. In Buddhism, they are considered "emblematic of the soul of man, resting always in calm above the surging activities of the world; existing in the sunlight pure and undefiled; rooted in the world of experience."
Hardy water-lily cultivars(Nymphaea species)
Tropical water-lily cultivars(Nymphaea species)
Curator Wayken Shaw
Wayken Shaw is the curator of the Judith D. Zuk Magnolia Plaza and Lily Pool Terrace, including the Annual and Perennial Borders. After earning a master's in landscape architecture from the University of Arizona, Wayken practiced urban design for nine years on both coasts before pursuing a more "hands-on" career in ornamental horticulture through a joint program between Bronx Community College and the New York Botanical Garden. Wayken sees gardening as an important connection between form and function, with plants as an aesthetic, educational, and physically comforting medium for defining space and creating a sense of place in our urban fabric.
Construction of Lily Pool Terrace began in 1919, shortly after the original conservatories were completed, and was finished in 1921. The pool surrounding the Jenkins Fountain originally had cattails planted between large rocks near the base of the fountain. Since the rocks and cattails were removed in the 1970s, an assortment of water-loving plants has been displayed seasonally, including elephant ears and pitcher plants.
Originally, the north pool was heated by hot water piping and was used to display tropical water-lilies, and the south pool was devoted to a collection of hardy species. In 1976, the global energy shortage and the economic crisis in New York City forced a decision to stop heating the north pool. Today the collection's focus is on hardy water-lilies and lotuses, with a smaller selection of tropicals. The hardy specimens are planted in large tubs set directly on the floor of the pools, while the tropical water-lilies and lotuses are raised above the pool floor to take advantage of the warmth from the pool's natural thermocline.
The small arc-shaped pool located at the northern end of the terrace is called the Lion's Head Pool for its fanciful wall fountain. It is the smallest of the pools and displays a rotating variety of species, such as papyrus and pitcher plants.


text: This episode of Long Night with Vish Khanna was recorded before a live studio audience at Longboat Hall in the Great Hall in Toronto, Ontario, as an actual TV show for FibeTV1. Our topic was 'do women thrive in the music industry' and our guests were broadcasting icon Denise Donlon, Fucked Up's Sandy Miranda, and Hooded Fang's April Aliermo. Produced by Ian Daffern, Vish Khanna, and FibeTV1. Photos by Colin Medley. With sidekick James Keast and our house band, the Bicycles. Sponsored by Freshbooks, Hello Fresh, Long and McQuade, Encore Records, and SappyFest. Watch the Long Night tv show on its YouTube channel.


text:
April 12, 2012
New sustainability resources at K-State Libraries
With Earth Day coming up, April is a natural time to talk about sustainability. Sustainability research encompasses a variety of disciplines at K-State, from sustainable agriculture, natural dyes, and sustainable textiles to sustainable business practices, biofuels, and LEED building design. Recognizing this, K-State Libraries strives to support the diversity of sustainability research on campus by providing access to an amalgam of online and print resources. The following is a small selection of our books, journals, and databases related to sustainability research:
- BuildingGreen: Provides information designed to help architects and those in construction to identify and use materials which will improve the environmental performance and reduce the adverse impact of buildings. Information about sustainable and environmentally friendly products is provided.
- "Protected Areas, Sustainable Land?" – edited by Catherine Aubertin and Estienne Rodary
- "Permaculture: Principles & Pathways Beyond Sustainability" – David Holmgren
- "World Soil Resources and Food Security" – edited by Rattan Lal, B.A. Stewart
- "Empire of the Beetle: How Human Folly and a Tiny Bug are Killing North America's Great Forests" – Andrew Nikiforuk
- "Jefferson National Forest: An Appalachian Environmental History" – Will Sarvis.
- Journal of Management and Sustainability
- Journal of Sustainability Education
- Solutions: For a Sustainable and Desirable Future
- Current Opinion in Environmental Sustainability
- Sustainability Science
In addition to resources, K-State Libraries has a team of librarians with complementary knowledge and skills to assist you with research, instruction or adding materials to the collection. This team includes Ellen Urton and Stephanie Cold from the undergraduate and community services department; Livia Olsen from faculty and graduate services; and Diana Farmer from collection development and acquisitions. K-Staters should feel free to contact any of these librarians with questions or requests.


text:
halconfenix wrote:ok... i get it... and yet its ironic that even if model kits are pretty much display pieces and action figures are made to be played with... the most impressive collectable figures of this last 2 decades are action figures yet all you can do with them is put then on display...
so i'm not going to argue anymore about "what's better than what"... in the end all depends on how a collector handles his/her figures regardless of how those were made in the first place (knowing that first hand thanks to photocomic making).
so before this thread gets derailed due to "unnecessary heat", only questions remaining are:
1) is koto really capable of re-launching the shinki line?
2) if yes... when?
1) I believe that they can. If they tell people they going to re-launch BS as action figure, people will be willing to wait.
2) I am not sure, but I think the earlier the better.
It seems you haven't read properly my previous comments. No one here denies the success of FA and MD, but here's the point; adding more mecha musume model kit line will end up as self-cannibalism by Koto, not to mention Bandai (and soon another comnpany) joining the market which will just end up as over saturated. On the other hand, considering how the mecha musume action figure market is barely exists and have only one product line, the competition will be far easier and the customer base will be bigger (action figure have way bigger market of consumers then model kits), furthermore you could avoid the possible bad outcomes which I mentioned above. So as you see, it's not just issue of action figure vs model kit as in my personal preference, but also an issue of rational conclusions seeing how the market is.Klinkin wrote:I really don't see why people are saying Koto's trying to kill the Busou Shinki line. Have you seen how the FA Girls line is doing? If anything, Koto making Busou Shinki like the FA Girls line is them trying to duplicate the success of one of their better model kit lines using a pre-existing IP that was said line's spiritual precursor. Everyone has their own opinions on model kits versus action figures, but you can't deny that Koto's model lines sell. Quite well. Also, for the record, Bandai's HG MS Girls are probably in response to Koto's various mecha musume kits, not the other way around.
As for Halcon's questions:
1. Of course. Between FA Girls, Megami Devices, and various other kit lines, Koto's demonstrated that mecha musume is something they can do quite well. Given their normal schedules, I'd expect that Arnval is basically ready to go, with the usual half-a-year timeframe between official listing and release. With that said...
2. ...Kotobukiya does not own the Busou Shinki IP. Konami does. Koto's licensed IPs before, but Konami has a level of head-up-anus that appears to be getting in the way. It's in Konami's hands now.


text:
It's Platinum, Baby: The tennis world has long enjoyed the wacky one-liners of Richard Williams, and it seems as though Olympic figure skating silver medalist Evgeni Plushenko is trying to join Williams in the creative-story realm. Plushenko's web site had its entry image (seen above) stating "Platinum of Vancouver", taking a jab at his second-place finish last week. Though the site now looks differently upon entry, Yahoo! Sports and other outlets nabbed the image before it was taken down. Now the site reads "What's Next?" while scrolling over the medals, which links to the 2014 Sochi Olympics web site. Does that mean Evgeni will stick with skating until then? Guess you can never be sure with him.
Sticking to the ice, American speedskater Ryan Bedford was supposedly convinced by older teammates to shave and dye his hair to resemble the American flag. See his 'do after the jump.
Rights Fighting: University of Maryland wrestler, Hudson Taylor, is a top-ranked grappler in the NCAA. The straight 23-year-old and his wife-to-be are also avid supporters of LGBT issues and support gay marriage. In an interview with OutSports.com, Taylor calls himself a "feminist". You go, boy.
Candied Britney: Britney Spears, in case you didn't know from her music video for "Radar", is a spokeswoman for Candies products. She offered fans a behind-the-scenes peek at her latest photo shoot for the brand. What do you think? We're not sure this one is gunna be a winner, y'all…
Martina's Gallery: The WTA has a great gallery up chronicling the career of Martina Navratilova. Not only do you get a good chunk of information out of the captions, but you get a wonderful view of Martina's fashions throughout the year. Our favorite is after the cut.
Differences Aside: Pete Sampras and Andre Agassi will put their differences aside in a couple weeks to participate in a "Hit for Haiti" fundraiser at Indian Wells alongside Roger Federer and Rafael Nadal. Sampras said he would like to "sit down" with Agassi after he was portrayed in poor light in Agassi's recently-released autobiography.
Ryan Bedford gets a new 'do. We hope he tipped his barber (and colorist).
Vintage Martina, circa 1977. We love the shape of this piece.
Navratilova has settled into an athletic look with Under Armour, always looking sharp and fit in exhibitions and public appearances.


text:
The PERFECT bread recipe for the beginning baker! Think Wonder Bread!
First, I want to mention I'm not talented enough to be able to claim I created this recipe. I found it on another forum and I really don't know who the original author is, but whoever it is, created a WINNER! This bread has a soft crust and interior (somewhat like store bought white but much tastier with a nicer texture) so for those of you who only want to tackle a crusty bread, this one is not for you. The crust also does not get very dark, but you could probably mist it with a bit of water if you want it darker.
But, if you're even a little like me in that you desperately want to be successful in making ANY kind of bread, you will LOVE this recipe! After I struggle for days to get a more complicated recipe to work for me, this one is a RELIEF to work on. I have never had a failure, even when I threw it together in a hurry. And EVERYONE here loves it! My grandson, who never asks for seconds of anything, asked me for a second slice of this tasty bread. My husband, who is difficult to please to say the least, is very happy when I use it to make his sandwiches to take with him to work in the morning. He's actually so proud that I can make it that he shares his sandwiches from time to time so his associates can sample it.
This is the recipe:
Combine in the slightly preheated bowl from your stand mixer (you can also do this entirely by hand, but it's a lot more work):
2 cups of 110-112 degree water
1 tablespoon plus one teaspoon instant yeast (a total of 4 teaspoons)
1 tablespoon sugar
Cover and let rise in a warm place for 5 minutes (to create warm place, I put my oven on 350 degrees for about 10 seconds and shut it off)
Add to the yeast mixture:
¼ cup oil
5 cups bread flour (I find the best way to measure flour for this recipe is to scoop it, as recommended by the America's Test Kitchen Family Baking Book. I have tried weighing it--which really should work--and spooning into the measuring cup, as recommended by the King Arthur Flour Baker's Companion, but with both methods the dough was too slack and I had to add flour.)
2 teaspoons salt
Knead until smooth and elastic. I use the dough hook to combine it for a couple of minutes (while scraping down the sides to help combine the ingredients) and knead for at least an additional 5 minutes on speed 2.
Place the dough (sometimes you have to aid it with a scraper to release it from the bottom of the mixer bowl as it doesn't seem to hold the ball shape on the hook each and every time) in a greased bowl, turn it, and cover it with plastic wrap that has been sprayed with a nonstick coating, such as Pam.
Cover and let rise in a warm place for 20-25 minutes. I use the minimum time for both the first and second rise. Punch the dough down and divide it into two equal portions. Then roll each piece into two rectangles that each measure approximately 10" by 14". Starting from the long end, roll each rectangle up in jelly roll fashion and tuck in the ends slightly. Pinch the seam together and place each loaf with the seam to the bottom on a greased 12" by 16" (or similar size) cookie sheet or shallow baking pan. I find the two loaves work fine on one pan. Diagonally slash each loaf about 3 times with a sharp, floured knife.
Lightly spray the loaves with nonstick spray and cover with plastic wrap. Let the loaves rise for 20-25 minutes in a warm place. Since I will have to preheat my oven while these loaves are rising, I cannot let the loaves rise in there and I turn on my toaster oven and leave it on for several minutes. After I shut if off, I check to see how hot the top has become and layer the appropriate amount of kitchen towels on top of it so that the bottom of the cookie sheet I will be placing on it doesn't get too hot. I then place the loaves on top of the towels on the toaster oven, making sure they are situated to the back (under the cabinets), where I believe the most heat would be trapped. Your situation may be different so I am only offering this as a suggestion.
Preheat the oven to 350 degrees and bake the bread for 20-25 minutes. I use the maximum time as this bread does not get a very dark crust. Let the bread cool for at least 10 minutes before slicing--it will still be warm.
ENJOY! (Bread is pictured below)


text:
Soundgarden / Badmotorfinger 25th anniversary super deluxe edition box set
Super Deluxe quick links: Amazon US
Soundgarden's third studio album, 1991's Badmotorfinger, is to be reissued as an extensive seven-disc super deluxe edition with an enormous amount of unreleased tracks, two DVDs with video material and a blu-ray audio with a 5.1 surround sound mix.
The four CDs in this package include the remastered album, a disc of studio outtakes (newly mixed from the multi-tracks) and the complete Paramount Theatre Concert from March 6, 1992 (across two CDs).
Of the two DVDs, one features the video of the Paramount Theatre gig, while the other includes the 'Motorvision' home video and eleven unreleased additional performance videos from 1992.
Finally, a blu-ray audio includes the full album mixed in 24bit / 96kHz 5.1 surround sound (no confirmation if this also includes hi-res stereo, but seems reasonably likely).
That's the audio and video, but this set comes with plenty of other 'stuff', much of which should be filed under 'pointless', including:
• A revolving Badmotorfinger icon box (batteries included)
• 12-inch 3D Lenticular Litho of the Badmotorfinger icon with silver foil
• Four band photo prints (8″ x 10″)
• Five-inch Badmotorfinger icon foil sticker
• 4-inch Triangular Spark Plug Silver Foil Sticker
• 25th Anniversary Badmotorfinger icon iron-on patch.
The super deluxe also comes with a 52-page booklet.
There is a two-CD version but rather than just give you all the demos, this disc includes nine of the outtakes/demos and seven tracks from the Paramount concert of the live audio.
A double vinyl LP edition features the 12-track album over three sides with a 25th anniversary etching on side 4.
All of these are issue on 18 November 2016. Non US links coming soon!
Compare prices and pre-order
Badmotorfinger - super deluxe edition
Compare prices and pre-order
Badmotorfinger - 2CD deluxe edition
[CD1: Original Album Remastered]
1. Rusty Cage
2. Outshined
3. Slaves & Bulldozers
4. Jesus Christ Pose
5. Face Pollution
6. Somewhere
7. Searching With My Good Eye Closed
8. Room A Thousand Years Wide
9. Mind Riot
10. Drawing Flies
11. Holy Water
12. New Damage
[CD2: Studio Outtakes]
1. Rusty Cage (Studio Outtake)*
2. Outshined (Studio Outtake)*
3. Slaves & Bulldozers (Studio Outtake)*
4. Jesus Christ Pose (Studio Outtake)*
5. Face Pollution (Studio Outtake) *
6. Somewhere (Studio Outtake)*
7. Searching With My Good Eye Closed (Studio Outtake)*
8. Room A Thousand Years Wide (Studio Outtake)*
9. Drawing Flies (Studio Outtake)*
10. Holy Water (Studio Outtake)*
11. Cold Bitch (Studio Outtake)*
12. She's A Politician (Studio Outtake)*
13. Black Rain (Studio Outtake)*
14. Birth Ritual (Studio Outtake)*
15. Blind Dogs (Studio Outtake)*
16. New Damage (with Brian May)
*Previously Unreleased
[CD3: Live At The Paramount (Part 1)]
Previously Unreleased
1. Searching With My Good Eye Closed
2. Hands All Over
3. Drawing Flies
4. Room A Thousand Years Wide
5. Gun
6. Flower
7. Little Joe
8. Big Dumb Sex
9. Face Pollution
10. Incessant Mace
11. Rusty Cage
[CD4: Live At The Paramount (Part 2)]
Previously Unreleased
1. Outshined
2. Mind Riot
3. Beyond The Wheel
4. Into The Void (Sealth)
5. Jesus Christ Pose
6. Hunted Down
7. Somewhere
8. Slaves & Bulldozers
[DVD1: Live At The Paramount]
Previously Unreleased
1. Searching With My Good Eye Closed
2. Hands All Over
3. Drawing Flies
4. Room A Thousand Years Wide
5. Gun
6. Flower
7. Little Joe
8. Big Dumb Sex
9. Face Pollution
10. Incessant Mace
11. Rusty Cage
12. Outshined
13. Mind Riot
14. Beyond The Wheel
15. Into The Void (Sealth)
16. Jesus Christ Pose
17. Hunted Down
18. Somewhere
19. Slaves & Bulldozers
[DVD2: Motorvision + More]
1. Searching With My Good Eye Closed
2. Rusty Cage
3. Outshined
4. Little Joe
5. Mind Riot
6. Room A Thousand Years Wide
7. Jesus Christ Pose
8. Slaves & Bulldozers
Bonus Videos:
*Previously Unreleased:
1. Outshined (Live in Dallas 4.29.92)*
2. Jesus Christ Pose (Live in Dallas 4.29.92)*
3. Rusty Cage (Live at Roseland Ballroom 5.09.92)*
4. Jesus Christ Pose (Live at Pinkpop Festival 7.08.92)*
5. Slaves & Bulldozers (Live at Pinkpop Festival 7.08.92)*
6. Slaves & Bulldozers (Live in Seattle 7.12.92)*
7. Face Pollution (Live in Seattle 7.12.92)*
8. Searching With My Good Eye Closed (Live in Seattle 7.22.92)*
9. Drawing Flies (Live in Miami 8.22.92)*
10. Cop Killer (Live in Miami 8.22.92)*
11. Room A Thousand Years Wide (Live in Miami 8.22.92)*
12. Jesus Christ Pose (Music Video)
13. Outshined (Music Video)
14. Rusty Cage (Music Video)
[Blu-Ray Audio 5.1 Surround Sound & Remastered Stereo]
*Previously Released
1. Rusty Cage*
2. Outshined*
3. Slaves & Bulldozers*
4. Jesus Christ Pose*
5. Face Pollution*
6. Somewhere*
7. Searching With My Good Eye Closed*
8. Room A Thousand Years Wide*
9. Mind Riot*
10. Drawing Flies*
11. Holy Water*
12. New Damage*
13. Cold Bitch*
14. She's A Politician*
15. Birth Ritual*
Bonus Videos:
16. Jesus Christ Pose (Music Video)
17. Outshined (Music Video)
18. Rusty Cage (Music Video)
2CD deluxe track listing (see image below)


text:
Canon U.S.A. Defines A New Category of Pro AV Compact Installation Projectors with the Introduction of New REALiS Models
Outstanding Picture Quality, Installation Flexibility, Operational Convenience, and Affordability Among the Advantages of New Compact Installation REALiS Projectors for Multiple Markets
MELVILLE, N.Y., May 29, 2013 – Canon U.S.A., Inc., a leader in digital imaging solutions, has introduced a new multimedia projector category that combines the exceptional picture quality of larger installation projectors with the plug-and-play convenience of portable models. Known as Pro AV Compact Installation LCOS (Liquid Crystal on Silicon) Projectors, this new Canon product category consists of the Canon REALiS WUX450, REALiS WUX400ST, REALiS WX520, and REALiS WX450ST Pro AV Compact Installation LCOS Projectors. All feature a trim design under 14 lbs. each, installation flexibility, easy set-up, and sophisticated operational advantages strategically designed for higher education, boardroom installations, museums, and many other professional markets.
Drawing on Canon's expertise in optical and imaging technologies, the new Pro AV Compact Installation LCOS Projectors feature newly designed built-in Genuine Canon projection lenses engineered to address a broad range of image-display requirements. The new Canon REALiS WUX450 and REALiS WX520 Pro AV Compact Installation LCOS Projectors offer placement flexibility with their advanced Genuine Canon projection lens that delivers a consistent fixed aperture of f/2.8 allowing for no light loss across its entire 1.8x zoom range. Designed for short-throw use, the new Canon REALiS WUX400ST and REALiS WX450ST Pro AV Compact Installation LCOS Projectors are equipped with an advanced Genuine Canon 1.35x zoom lens with generous horizontal and vertical lens-shift adjustability for distortion-free image quality in environments where the projector must be located close to the screen or display surface.
"Canon's new REALiS WUX450, REALiS WUX400ST, REALiS WX520, and REALiS WX450ST Pro AV Compact Installation LCOS Projectors blend the high-quality and exceptional detail, clarity and contrast of large projector models with the portability of smaller models," explained Yuichi Ishizuka, executive vice president and general manager, Imaging Technologies and Communications Group, Canon U.S.A. "The demand for installation projectors is growing across many professional markets, and Canon is demonstrating its commitment to these users by developing this entirely new category of the Pro AV Compact Installation LCOS Projectors, which integrate the latest technologies to provide exceptional user benefits, convenience, and affordability."
All of Canon's new Pro AV Compact Installation LCOS Projectors employ a new Canon AISYS 5.0 optical engine that helps improve the management of light through the projectors' next-generation Canon LCOS display panels. The result is the projection of high-resolution images with intricate detail, crisp contrast, high brightness, deep blacks, precise color, and reduced blur during fast-moving movie scenes. The REALiS WUX450 and REALiS WUX400ST deliver WUXGA (1920 x1200) resolution imagery with 4500 and 4000 lumens of brightness, respectively. The REALiS WX520 and REALiS WX450ST provide WXGA+ (1440 x 900) resolution imagery with 5200 and 4500 lumens, respectively. All models deliver a 2000:1 contrast ratio, 16:10 widescreen aspect ratio images, versatile connectivity and management controls, sophisticated image-processing and edge-blending capabilities, energy efficiency, and a lower total cost of ownership as compared to previous models.
Markets for the new Canon REALiS WUX450, REALiS WUX400ST, REALiS WX520, and REALiS WX450ST Pro AV Compact Installation LCOS Projectors include large classrooms, lecture halls, and auditoriums, houses of worship, museums and galleries, corporate boardrooms and conference rooms, ad agencies and photo studios, video and motion picture post-production facilities, training simulators, government command and control rooms, medical training and conference rooms, and videoconferencing sites.
Installation Flexibility
Approximately 25 percent smaller than previous Canon Pro AV Series projectors, the new projectors feature a new heat-exhaust design and a flat chassis which allows for a wide variety of installation-placement choices. Optional feet can be installed on the top of each projector for inverted ceiling-type mounts. Two units can be stacked to double light output, yet still fit into a compact space. The 1.8x zoom lens built into the REALiS WUX450 and REALiS WX520 includes a mechanical lens-shift feature for increased installation flexibility, enabling both projectors to be installed vertically, pointing up or downwards.
The REALiS WUX400ST and REALiS WX450ST Pro AV Compact Installation LCOS Projectors for short-throw environments include a built-in 1.35x distortion-free zoom lens and a 0-75 percent vertical and ± 10 percent horizontal lens-shift adjustment feature. This combination enables these projectors to be used for short-throw display applications, including both front- and rear-projection installations. Short-throw projection applications can include environments where the presenter and the display screen must be in close proximity because of room size, design, or other unique factors, such as a ceiling that is too low for mounting a projector.
Canon's new Pro AV Compact Installation LCOS Projectors have a long-life lamp that provides up to 4000 hours of operation. Easy access lamp and filter covers help simplify lamp replacement and filter cleaning, even while installed. Power consumption for the REALiS WUX450 and REALiS WX520 projectors equals less than .081 watts per lumen at its brightest mode.
Imaging Versatility
Although integrating many unique technologies, the new Canon REALiS WUX450, REALiS WX520, REALiS WX450ST, and REALiS WUX400ST Pro AV Compact Installation LCOS Projectors are simple to operate and provide easy set-up features. These can be accessed using a configurable control panel on the side of each unit and by using the projected installation and professional-settings menus. The extensive image-processing capabilities of these projectors provide multiple user benefits. These include a dozen built-in test patterns (triggered via the remote control unit and user-accessible onscreen menus) for fast, simple image calibration without the need for a pattern generator or a PC. An innovative four-point keystone-adjustment function enables users to adjust each corner of the image independently while also keeping focus consistent, and to achieve true diagonal projection as well as moiré reduction.
An easy-to-use built-in edge-blend function with precision luminance ramp adjustment and pixel-overlap control enables the new Canon Pro AV Compact Installation LCOS Projectors to be used in multi-projector configurations for the display of large, seamless images with precisely matched edges. Easy registration adjustment for perfect edge-blend alignment is further enabled by the combination of the low "TV distortion" characteristics of the projectors' zoom lenses and an integrated micro digital lens shift adjustment (a separate feature from the projectors' mechanical lens-shift adjustment capability). The result is pixel-precise image blending for seamless multi-projector displays.
Advanced Management and Connectivity
Built into the new Canon Pro AV Compact Installation LCOS Projectors is a full suite of networking features, including full control over IP and content streaming. An Ethernet (LAN) interface enables advanced remote control and monitoring capabilities including power management, usage tracking, and other control functions. The REALiS WUX450, REALiS WX520, REALiS WX450ST, and REALiS WUX400ST are Crestron RoomView™-compatible.
Key networking features also include a content-streaming capability, which allows one or more PCs to connect to a projector over a standard LAN to share content. This NMPJ (Network Multi Projection) system has the ability to display content from four different PC's on a single screen. Content can be streamed from any point with a network connection to a projector, either within a room or in multiple locations, simplifying installation. The NMPJ system allows for video streaming (without audio) through the LAN to the projector in four ways: Meeting mode – to share a participant's screen with everyone (or share between remote sites via the Internet).
Classroom mode – allows an instructor to select which PC screen to project; up to four PC screens can be shown simultaneously.
Broadcast mode – images can be projected at multiple sites simultaneously. Direct mode – enables a projector to be connected directly to a PC using a LAN cable.
Input terminals on the new Canon Pro AV Compact Installation LCOS Projectors include a USB port for "PC-less" presentations of JPEGs and other content directly from a thumb drive or other USB-equipped flash-memory data storage device (and for firmware updates). Other inputs include DVI, component video, HDMI, and two mini-jack audio inputs. A special Picture-by-Picture Processor allows for the simultaneous use of HDMI and DVI in split-screen mode. A 5-watt mono speaker is built-in for audio playback without peripheral components.
The Canon REALiS WUX450, REALiS WX520, REALiS WUX400ST, and REALiS WX450ST are also available in "D" versions (REALiS WUX450 D Pro AV Compact Installation LCOS Projector, REALiS WX520 D ProAV Compact Installation Projector, REALiS WUX400ST D Pro AV Compact Installation LCOS Projector and REALiS WX450ST D Pro AV Compact Installation LCOS Projector) featuring a DICOM® Simulation mode and superb 21-step grayscale gradation display capabilities designed to effectively project high-quality medical images such as X-rays, CAT scans and MRIs. Please note, these models are not cleared or approved for medical diagnosis and should not be used for diagnosis purposes.
Price and Availability The new Canon REALiS WUX450, REALiS WUX450 D, REALiS WX520, and REALiS WX520 D Pro AV Compact Installation LCOS Projectors have suggested list prices of $5,499.00, $6,199.00, $4,999.000 and $5,699.00, respectively. All are expected to be available through authorized Canon dealers by September 2013.
The new Canon REALiS WUX400ST, REALiS WUX400ST D, REALiS WX520ST and REALiS WX450ST D Pro AV Compact Installation LCOS Projectors have suggested list prices of $6,899.00, $7,499.00, $6,299.00 and $6,899.00, and are expected to be available by September 2013.
For more information please visit www.usa.canon.com/projectors.
About Canon U.S.A., Inc.
Canon U.S.A., Inc., is a leading provider of consumer, business-to-business, and industrial digital imaging solutions. With approximately $40 billion in global revenue, its parent company, Canon Inc. (NYSE:CAJ), ranks third overall in U.S. patents registered in 2012† and is one of Fortune Magazine's World's Most Admired Companies in 2013. In 2012, Canon U.S.A. received the PCMag.com Readers' Choice Award for Service and Reliability in the digital camera and printer categories for the ninth consecutive year, and for camcorders for the past two years. Canon U.S.A. is committed to the highest level of customer satisfaction and loyalty, providing 100 percent U.S.-based consumer service and support for all of the products it distributes. Canon U.S.A. is dedicated to its Kyosei philosophy of social and environmental responsibility. To keep apprised of the latest news from Canon U.S.A., sign up for the Company's RSS news feed by visiting www.usa.canon.com/rss.
†Based on weekly patent counts issued by United States Patent and Trademark Office.
All referenced product names, and other marks, are trademarks of their respective owners.
DICOM is the registered trademark of the National Electrical Manufacturers Association for its standards publications relating to digital communications of medical information.
Availability, prices, and specifications of all products are subject to change without notice. Actual prices are set by individual dealers and may vary.


text:
- Home
- Government
- Departments
- Town Clerk
- Business Licenses
Business Licenses
Applications for business licenses are submitted to the Town Clerk's Office through the OpenGov's online registration system. New applicants will have to create an individual account for their business. Follow the instructions to complete your applications and process your payment. The required fees (see link below) can be paid online with the applications, or by check delivered to the Town Clerk's office.
If applicable, the following must be provided; all documents should be scanned and attached to the renewal applications online:
- A copy of your current retail sales permit
- Current Department of Health license
- Those businesses which have Town potable water supply and/or a dedicated fire protection connection must provide annual written certification that their testable potable water backflow device is operating properly.
Liquor license applicants should review the Town Council's Liquor License Rules and Regulations (see below link) and Liquor License Application Requirements (see below link) before beginning the application process. We recommend that you contact the Town Clerk's Office for additional information.
- General Business License assistance: Contact Linda Stedman at x1230 or email
- Liquor License assistance: Contact Susan Flynn at x1232 or email
All license applications will be reviewed by the individual departments within the Town to ensure that the licensee is in compliance with all State Laws and Town Ordinances before being placed on the Town Council agenda for approval. You will receive emails from the Town during the review process, and any deficiencies will be noted so that you can address them immediately.
- Apply for a Business License Online
- Town License Schedule of Fees
- Town Council's Liquor License Rules & Regulations
- Town Liquor License Application Requirements
- State of RI Liquor Control Administration Rules & Regulations
- State of RI General Laws
- RI Department of Health
- RI Division of Taxation
- RI Secretary of State Business Portal
Town Clerk's Office
Physical Address
180 High Street
Wakefield, RI 02879
Phone: (401) 789-9331 x1230Fax: (401) 788-9792
Susan Flynn
Town Clerk, Probate Clerk & Canvassing Clerk
Nichole Romane
Deputy Town Clerk
Have you registered for emergency alerts?
Stay informed by signing up today! Click here for more information.